Status:
UNKNOWN
Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion
Lead Sponsor:
Rothman Institute Orthopaedics
Conditions:
Ketorolac
Joint Fusion
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
In the midst of the opioid crisis, the use of non-narcotic pain medication has garnered increased interest, particularly in the field of orthopaedic surgery, where narcotic medications are routinely p...
Eligibility Criteria
Inclusion
- Patients over the age of 18 undergoing outpatient primary 1st MTPJ fusion by a fellowship-trained foot and ankle orthopaedic surgeon at the Rothman Orthopaedic Institute
Exclusion
- Patients undergoing revision 1st MTPJ fusion;
- Patients with any allergies to any study medication;
- Patients with documented chronic narcotic use;
- Patients with renal insufficiency, as defined by history and preoperative creatinine level (Cr ≥ 2.1 mg/dl);
- Patients who are pregnant;
- Patients undergoing inpatient procedure.
Key Trial Info
Start Date :
May 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04872283
Start Date
May 23 2019
End Date
December 31 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States, 19107